Racial differences in long-term survival among patients with coronary artery disease

Kevin L Thomas1, Emily Honeycutt, Linda K Shaw

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. kevin.thomas@duke.edu

American Heart Journal
|October 12, 2010
PubMed

Insights

Black patients with coronary artery disease (CAD) have lower long-term survival than white patients. This disparity is linked to risk factors and treatment, but not fully explained by them.

Area of Science:

  • Cardiology
  • Health Disparities
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in the US for both Black and White populations.
  • Limited data exist on the long-term prognosis for Black patients with coronary artery disease (CAD).
  • Understanding clinical determinants of outcome in Black patients with CAD is crucial.

Purpose of the Study:

  • To compare the long-term survival of Black and White patients with significant coronary artery disease (CAD).
  • To identify major clinical and demographic factors associated with survival differences.
  • To investigate the role of initial treatment in survival disparities.

Main Methods:

  • Analysis of 22,618 patients (3,314 Black) with significant CAD findings from cardiac catheterization (1986-2004).
  • Kaplan-Meier and Cox modeling used for survival comparisons by race and gender.
  • Follow-up data collected through June 2006 (median 7.6 years).

Main Results:

  • Black patients with CAD were younger, more often female, had lower incomes, and higher rates of hypertension, diabetes, and heart failure.
  • At 15-year follow-up, Black women had the lowest survival (41.5%) and White men the highest (45.8%).
  • Blacks were less likely to receive initial coronary revascularization (OR 0.66). Black race remained an independent predictor of lower survival (HR 2.54) after adjustments.

Conclusions:

  • Black patients with CAD exhibit lower long-term survival compared to White patients.
  • Differences in cardiovascular risk factors and revascularization rates partially explain, but do not fully account for, the survival gap.
  • Further research is needed to address the unexplained factors contributing to lower survival in Black individuals with CAD.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...